GlassScriptPhysician profile
Kristin L Ault
NPI 1609078211
$4,726.77
in general payments reported to CMS, 2019-2025
39 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $765 · 2021: $820 · 2022: $436 · 2023: $681 · 2024: $828 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $743.18 | 2019-2023 | Belsomra, Steglatro |
| Novo Nordisk INC | $638.27 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $569.74 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $413.96 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $402.07 | 2021-2025 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $253.37 | 2021-2024 | |
| Astellas Pharma US INC | $234.01 | 2019-2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $198.58 | 2019-2023 | Breztri |
| Pfizer INC. | $184.63 | 2019-2024 | |
| Mylan Specialty L.P. | $155.50 | 2019-2023 | Yupelri |
| Abbvie INC. | $126.27 | 2021-2024 | Linzess, Viberzi |
| Allergan, INC. | $98.21 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.89 | 2019 | |
| Abbott Laboratories | $70.08 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.56 | 2020-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Ault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.